Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial

NCT06024291 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Overweight and Obesity
Dyslipidemias
Blood Pressure
Cardiovascular Diseases
Metabolic Disease

Interventions

OTHER: 8-week HIIT programme
OTHER: Physical activity recommendation

Sponsor

University of Basel

Collaborators

[object Object]
[object Object]